J.P. Morgan Life Sciences Private Capital has invested in Turbett Surgical, according to a news release.

Turbett, founded in 2013 and based in Henrietta, New York, is a medical equipment company that manufactures mobile sterilization pods and consumable filters for surgical equipment sterilization.

J.P. Morgan Life Sciences Private Capital is the life sciences

Data Privacy Day offers a natural checkpoint to take stock of a fast‑moving legal landscape. As of January 1, 2026, several significant U.S. state privacy laws and regulatory updates are now live, with additional U.S. and global milestones queued up throughout 2026. Below we summarize important changes already in effect and highlight issues to monitor as the year unfolds.

On Jan. 14, 2026, the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) jointly released the “Guiding Principles of Good AI Practice in Drug Development,” a set of 10 high-level principles intended to steer the safe and responsible use of AI across the product lifecycle. While not formal industry guidance, the

On January 16, 2026, the Secretary of War Pete Hegseth posted a video on social media announcing that the Department of War will conduct a “line‑by‑line review of every small business, sole source, 8(a) contract that is over $20 million,” focusing on impermissible pass‑throughs to large businesses.  This action by the DoW aligns with broader federal investigations and audits of the 8(a) program.

Lead Capital Partners (LCP) has announced an investment in PedsOne.

PedsOne, founded in 2011 and based in Nashville, Tennessee, is a provider of outsourced revenue cycle management and consulting services to independent pediatric practices throughout the United States.

LCP, founded in 2011 and based in Nashville, Tennessee, is a lower middle market private

WindRose Health Investors has announced an investment in Avalon Healthcare Solutions.

Avalon, founded in 2013 and based in Tampa, Florida, is a healthcare technology company that manages the appropriate use of routine and genetic diagnostic laboratory tests on behalf of health plan clients.

WindRose, founded in 2000 and based in New York, pursues

Eir Partners Capital announced the closing of its third fund.

The fund, Eir Partners III, closed with aggregate capital commitments of $1 billion, exceeding its target of $800 million.

Eir, founded in 2015 and based in Miami, is a middle market private equity firm focused on healthcare technology and tech-enabled services. Eir’s targeted stages